Studies show that blood clotting responses vary from person to person. So, despite the range of anti-thrombotic therapies currently available, these approaches are usually “one size fits all” and can be ineffective and/or cause unwanted side effects for many patients.

In this presentation, Professor Jon Gibbins, University of Reading, explores the role of platelets in haemostasis, their importance in thrombosis research and therapy development, and how precision medicine approaches are being developed with the aim to better preventing thrombosis in individual patients.

This video is an output from the Future Blood Testing Network. which is funded by EPSRC under Grant Number EP/W000652/1.